➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Colorcon
McKesson
Johnson and Johnson

Last Updated: January 19, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Meso-Erythritol

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Meso-Erythritol?

Meso-Erythritol is an investigational drug.

There have been 20 clinical trials for Meso-Erythritol. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2018.

The most common disease conditions in clinical trials are Mesothelioma, Ovarian Neoplasms, and Lung Neoplasms. The leading clinical trial sponsors are Hrain Biotechnology Co.,Ltd., Stony Brook University, and Kafrelsheikh University.

There is one US patent protecting this investigational drug and twenty-two international patents.

Recent Clinical Trials for Meso-Erythritol
TitleSponsorPhase
Efficacy of Sn-protoporphyrin IX (SnPPIX) and Sulfonated Tetranaphthyl Porphyrin Against Covid-19Kafrelsheikh UniversityPhase 1
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaNational Malaria Control Program, TanzaniaPhase 4
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in TanzaniaNational Institute for Medical Research, TanzaniaPhase 4

See all Meso-Erythritol clinical trials

Clinical Trial Summary for Meso-Erythritol

Top disease conditions for Meso-Erythritol
Top clinical trial sponsors for Meso-Erythritol

See all Meso-Erythritol clinical trials

US Patents for Meso-Erythritol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Meso-Erythritol   Start Trial Solvent resistant polyetherpolyurethane products The Dow Chemical Company (Midland, MI)   Start Trial
Meso-Erythritol   Start Trial Production, isolation, and identification of novel antifungal compounds Board of Trustees Operating Michigan State University (East Lansing, MI)   Start Trial
Meso-Erythritol   Start Trial Acetoacetoxyethyl methacrylate in the cure of epoxy resins Texaco Chemical Company (White Plains, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
AstraZeneca
Colorcon
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.